Arbor Realty Trust, Inc. (ABR): what the price requires

At today's price, Arbor Realty Trust, Inc. (ABR) is priced for 6.3% return on equity. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-19 · Source: https://boothcheck.com/report/ABR

Headline

FieldValue
TickerABR
CompanyArbor Realty Trust, Inc.
Current price$4.90/sh
CompositionStructured Business 95% / Agency Business 5%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed6.3%
Return on equity now9.6%
ROE gap-3.3pp
Price-to-book0.42x

Solve inputs: computed at a 10.8% cost of equity with 3% terminal growth over a 5-year stage, on common book equity (FY2026); each 1pp of cost of equity moves the implied ROE ~0.4pp.

Reconcile: at the x-ray's 9.3% required return this reads ~5.7%; the models below use their own rates.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
cohort percentile (of 10 peers)0
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and relative-multiple and growth-DCF value, while earnings-power lands below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.97x4justifies
Earnings2.25x2expensive
Relative0.56x3justifies
Growth0.26x3justifies

Families that justify the price: Asset, Relative, Growth Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 4.4%); the inversion above states its own rate.

Per-Model Detail (n=12)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$0.00noFCF base $0.2B, growth -10% (input: historical growth), terminal g 0.5%, WACC 4.4%, 5yr projection
DCF Exit MultipleGrowth$1.942.53xyesExit EV/EBITDA: 450.3x / 452.3x / 454.3x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$14.980.33xyesP/E 24.16x (blended: static sector reference 35x + trailing (TTM) 8x), scenarios: 20.4x / 24.2x / 27.9x (bear / base = reference held flat / bull), EV/EBITDA 44x
Simple DDMGrowth$29.620.17xyesDPS $1.38, g=4.4% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$18.660.26xyesStage 1: -3% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$6.410.76xyesBV/sh $13.55, ROE (TTM) 4.4%, ke 9.3%
Two-Stage Excess ReturnAsset$4.191.17xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowthno
Growth-Adjusted P/ERelativeno
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAsset$3.621.35xyesBV $13.55 + 5yr PV of (ROE (TTM) 4.4% − Kₑ 9.3%) × BV; BV grows 2.8%/yr
Graham NumberAsset$13.750.36xyes√(22.5 × FFO/share $0.62 × BVPS $13.55) — Graham's conservative floor
EV/EBITDA RelativeRelative$0.01490.00xyesEBITDA $0.03B × sector EV/EBITDA 20.0x (excluded from median)
FCF YieldEarnings$0.01490.00xyesFCF $213.6M / Kₑ 9.3% — zero-growth perpetuity (excluded from median)
SBC-Adj FCF YieldEarnings$0.01490.00xyesSBC-adj FCF $0.20B (FCF $0.21B − SBC $0.01B) capitalized at Kₑ (excluded from median)
Ben Graham FormulaEarnings$1.303.77xyesFFO/share $0.62 × (8.5 + 2×-3.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelative$6.310.78xyesRevenue $0.22B × sector P/S 6.0x
PEG Fair ValueRelativeno
Earnings YieldEarnings$6.700.73xyesFFO/share $0.62 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative$8.750.56xyesFFO/share $0.62 × 14.2x P/FFO (route cohort median, n=85); FFO $0.13B (FFO incl. D&A + impairments, FY2025, companyfacts), shares 212M
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Share count CAGR (dilution)3.4%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

Start with how far the price sits below the methods, because the gap is the entire bull case. Arbor trades at about $5.19 (June 27, 2026) against a book value of $13.55 per share, so the stock changes hands at roughly half of stated book. The asset-based methods reflect that discount as opportunity: the simple excess-return method lands near $6.41, the funds-from-operations multiple near $8.24, and the relative valuation higher still. Inverting the price shows the market assuming the trust earns only about a 6.3% return on equity going forward, well below the roughly 9.6% it has recently delivered. If book value is anywhere near real and the return normalizes, the stock is worth meaningfully more than half of book, and the dividend yield on the reset payout is substantial.

The franchise underneath is more durable than the loan book alone suggests. Arbor runs a large fee-based agency servicing business, about $36.31 billion in the servicing portfolio, that generates recurring, capital-light fee income largely insulated from credit cycles. That servicing annuity is a real asset that the simple price-to-book read understates, because servicing rights throw off steady cash regardless of where the bridge-loan book sits. Agency originations of $707.6 million and structured originations of $767.6 million in the quarter show the origination engine still running. A mortgage trust with a large servicing book has a second income stream that pure balance-sheet lenders lack.

The credit picture, while the central risk, is showing tentative signs of working through. Nonperforming assets decreased about $100 million from the prior quarter to roughly $1 billion, and management reset the dividend to $0.17 per quarter, a level it described as sustainable for the rest of the year. A sustainable, covered dividend on a stock at half of book is a high cash yield, and if the credit cycle has passed its worst, the combination of a fee-servicing annuity, a normalizing return on equity, and a deep discount to book is the setup value buyers look for in a beaten-down financial. The bull case is that the market has priced ongoing deterioration that the asset value and the servicing franchise do not support.

Bear Case

The disruption to the thesis is not a competitor, it is the credit cycle running through Arbor's own loan book, and the numbers are sobering. Nonperforming assets stand at roughly $1 billion, and the FY2025 10-K's non-accrual roll-forward shows the machinery of stress in motion: large balances of loans progressing past 60 days due, loans transferred to real estate owned, and hundreds of millions of dollars of additional loans classified as non-accrual over the period (FY2025 10-K, accession 0001253986-26-000019). This is a multifamily bridge lender, and the multifamily bridge segment, floating-rate loans on transitional apartment properties made during the low-rate era, is exactly where higher rates and softening rents have pressured borrowers most. The stock trades at half of book because the market does not trust the book: every dollar of stated equity is suspect until the credit migration stops.

The earnings already show the cost. First-quarter 2026 GAAP net income was a breakeven $0.6 million, and distributable earnings were dragged to $0.07 per share by $22.9 million of net realized losses from legacy assets. The board's decision to cut the quarterly dividend to $0.17 is the clearest signal of all: a mortgage REIT cuts its dividend when its earning power has genuinely declined, and Arbor cut it. The new payout may be sustainable, but the cut crystallizes that the prior dividend was not, and there is no guarantee the next leg of credit losses does not force another reset.

The structural fragility is the funding model. A leveraged mortgage trust borrows short and lends long, so it is exposed to both credit losses on its assets and to the cost and availability of its own financing. If realized losses keep eroding book value, the discount to book is not a bargain, it is the market correctly marking the equity toward its true worth. The two-stage methods that assume continued deterioration land near or below the price for that reason. The bear case is direct: Arbor is a credit story in the middle of a multifamily downturn, with $1 billion of nonperformers, a freshly cut dividend, and legacy losses still flowing through earnings. The half-of-book price is not obviously cheap when the book itself is the thing in question.

Valuation

A financial is worth the return it earns on its capital, so the price is read off price-to-book rather than an operating multiple. At $5.19 the market is paying about 0.5 times book, and inverting that implies the trust sustains a return on equity of only about 6.3%, against the roughly 9.6% it has recently earned, solved at a 10.8% cost of equity. Treat the figures as approximate. The stock sits in the lower half of its peer group's price-to-book, so the read is within range rather than extreme: the market is pricing a meaningful but not catastrophic decline in returns. The entire valuation hinges on one question the multiple cannot answer, which is whether the stated book value is real.

The valuation X-ray needs careful handling because the methods split on exactly that question. The asset methods that take book value at face value land above the price: simple excess return near $6.41, the funds-from-operations multiple near $8.24, the relative valuation higher. The methods that assume continued deterioration, the two-stage dividend model and the two-stage excess-return method, land near or below the price. Several earnings-power methods produce unstable outputs because the trailing earnings are depressed by realized losses. So the X-ray does not give a clean answer; it gives a conditional one. If book value holds, the stock is cheap at half of book. If credit losses keep eroding it, the discount is justified.

The honest conclusion is that the valuation is unusually dependent on a single judgment: the quality of the multifamily bridge book. The reset dividend, if sustainable, offers a high cash yield on a half-of-book price, and the servicing franchise is a real asset the simple read understates. But with $1 billion of nonperformers and legacy losses still flowing through, a buyer is underwriting the book value as much as the business.

Catalysts

The first-quarter 2026 report, released in late April, was the pivotal event and it was mixed-to-weak. GAAP net income was essentially breakeven at $0.6 million, or $0.00 per diluted share, and distributable earnings were $0.07 per share including $22.9 million of net realized losses from legacy assets, or about $0.18 excluding the one-time items. The board adjusted the quarterly dividend to $0.17 per share, a level management expects to be sustainable for the rest of the year. Nonperforming assets decreased about $100 million from the prior quarter to roughly $1 billion, the fee-based servicing portfolio stood at about $36.31 billion, and the trust originated $707.6 million of agency and $767.6 million of structured loans.

The forward catalysts all run through credit and the dividend. The items to watch are the trajectory of nonperforming assets and whether the quarter-over-quarter decline continues, the pace of legacy-asset resolution and any further realized losses, the sustainability of the reset $0.17 dividend, the trend in book value as credit works through, and the health of the multifamily lending market under the prevailing rate environment. The servicing portfolio and origination volumes signal the franchise's ongoing activity. The next quarterly print, due in late July, is the key checkpoint for whether the credit cycle is stabilizing or whether further deterioration forces another book-value markdown or dividend action. A continued decline in nonperformers with a held dividend would support the discount-to-book thesis; renewed credit migration would validate the market's skepticism.

Sources: Arbor Realty Trust Q1 2026 results and dividend adjustment (stocktitan.net, gurufocus.com); ABR Q1 2026 financial results coverage (quiverquant.com).

Peer Cohorts (Per Segment, With Filing Citations)

Structured Business (reported)

Agency Business (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive ABR report on boothcheck